Intercept failed NASH candidate precipitated Alfasigma acquisition Markets September 30, 2023 Mohammed Haneefa Nizamudeen After the failure of Intercept Prescribed drugs’ (ICPT) Ocaliva (obeticolic acid) for nonalcoholic steatohepatitis (NASH) in June,…
